AKUMS
Invest with MTF
Invest Now
Invest in Akums Drugs & Pharmaceuticals with 3.3X leverage
Performance
- Low
- ₹463
- High
- ₹475
- 52 Week Low
- ₹405
- 52 Week High
- ₹623
- Open Price₹469
- Previous Close₹467
- Volume129,048
- 50 DMA₹442.37
- 100 DMA₹451.94
- 200 DMA₹494.30
Investment Returns
- Over 1 Month + 5.38%
- Over 3 Month + 3.4%
- Over 6 Month -2.41%
- Over 1 Year -16.43%
Smart Investing Starts Here Start SIP with Akums Drugs & Pharmaceuticals for Steady Growth!
Akums Drugs & Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 23.3
- PEG Ratio
- 1.6
- Market Cap Cr
- 7,378
- P/B Ratio
- 2.3
- Average True Range
- 13.4
- EPS
- 19.54
- Dividend Yield
- 0
- MACD Signal
- 2.05
- RSI
- 69.16
- MFI
- 80.62
Akums Drugs & Pharmaceuticals Financials
Akums Drugs & Pharmaceuticals Technicals
EMA & SMA
Current Price
₹468.75
+
1.55
(0.33%)
- Bearish Moving Average 2
- Bullish Moving Average 14
- 20 Day
- ₹445.33
- 50 Day
- ₹442.37
- 100 Day
- ₹451.94
- 200 Day
- ₹494.30
Resistance and Support
468.97
- R3 486.18
- R2 480.52
- R1 474.63
- S1 463.08
- S2 457.42
- S3 451.53
Akums Drugs & Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-13 | Quarterly Results | |
| 2025-11-13 | Quarterly Results | |
| 2025-08-08 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-06 | Quarterly Results |
Akums Drugs & Pharmaceuticals F&O
About Akums Drugs & Pharmaceuticals
- NSE Symbol
- AKUMS
- BSE Symbol
- 544222
- Managing Director
- Mr. Sanjeev Jain
- ISIN
- INE09XN01023
Similar Stocks to Akums Drugs & Pharmaceuticals
Akums Drugs & Pharmaceuticals FAQs
Akums Drugs & Pharmaceuticals share price is ₹468 As on 11 February, 2026 | 01:58
The Market Cap of Akums Drugs & Pharmaceuticals is ₹7377.8 Cr As on 11 February, 2026 | 01:58
The P/E ratio of Akums Drugs & Pharmaceuticals is 23.3 As on 11 February, 2026 | 01:58
The PB ratio of Akums Drugs & Pharmaceuticals is 2.3 As on 11 February, 2026 | 01:58
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.